发明名称 METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION
摘要 Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
申请公布号 US2013253026(A1) 申请公布日期 2013.09.26
申请号 US201313838267 申请日期 2013.03.15
申请人 EAGLE PHARMACEUTICALS, INC. 发明人 SUNDARAM SRIKANTH;TARRIFF SCOTT L.
分类号 A61K31/4184 主分类号 A61K31/4184
代理机构 代理人
主权项
地址